Cargando…

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance

Determination of the clinical relevance of rare germline variants of uncertain significance (VUSs) in the BRCA2 cancer predisposition gene remains a challenge as a result of limited availability of data for use in classification models. However, laboratory-based functional data derived from validate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richardson, Marcy E., Hu, Chunling, Lee, Kun Y., LaDuca, Holly, Fulk, Kelly, Durda, Kate M., Deckman, Ashley M., Goldgar, David E., Monteiro, Alvaro N.A., Gnanaolivu, Rohan, Hart, Steven N., Polley, Eric C., Chao, Elizabeth, Pesaran, Tina, Couch, Fergus J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008494/ https://www.ncbi.nlm.nih.gov/pubmed/33609447 http://dx.doi.org/10.1016/j.ajhg.2021.02.005

Ejemplares similares

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance
por: Iversen, Edwin S., et al.
Publicado: (2022)

Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
por: Li, Hongyan, et al.
Publicado: (2019)

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort
por: Hu, Chunling, et al.
Publicado: (2020)

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
por: LaDuca, Holly, et al.
Publicado: (2019)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance
por: Lyra, Paulo C. M., et al.
Publicado: (2020)

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield
por: Horton, Carolyn, et al.
Publicado: (2022)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C
por: Hu, Chunling, et al.
Publicado: (2023)

Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models
por: Hart, Steven N., et al.
Publicado: (2018)

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay
por: Hu, Chunling, et al.
Publicado: (2022)

Classification of the canonical splice alteration MUTYH c.934-2A > G is likely benign based on RNA and clinical data
por: Hernandez, Felicia, et al.
Publicado: (2022)

Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
por: Pesaran, T., et al.
Publicado: (2016)

Classifying Variants of Undetermined Significance in BRCA2 with Protein Likelihood Ratios
por: Karchin, Rachel, et al.
Publicado: (2008)

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
por: Chenevix-Trench, Georgia, et al.
Publicado: (2007)

Universal Multi Gene Panel Testing For Individuals With Pheochromocytomas And Paragangliomas
por: Horton, Carolyn, et al.
Publicado: (2021)

Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance
por: Woods, Nicholas T, et al.
Publicado: (2016)

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
por: Pritzlaff, Mary, et al.
Publicado: (2016)

Functional characterization of 84 PALB2 variants of uncertain significance
por: Wiltshire, Timothy, et al.
Publicado: (2019)

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)

The functional impact of variants of uncertain significance in BRCA2
por: Mesman, Romy L. S., et al.
Publicado: (2018)

Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2
por: Tram, Eric, et al.
Publicado: (2013)

Classifying Supporting, Refuting, or Uncertain Evidence for Pneumonia Case Review
por: South, Brett R., et al.
Publicado: (2015)

Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing
por: Horton, Carolyn, et al.
Publicado: (2023)

Uncertain science ... uncertain world
por: Pollack, Henry N
Publicado: (2003)

Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?
por: Cheon, Jae Yeon, et al.
Publicado: (2014)

BRCA1 frameshift variants leading to extended incorrect protein C termini
por: Nepomuceno, Thales C., et al.
Publicado: (2023)

Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
por: Cunningham, J. M., et al.
Publicado: (2014)

Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices
por: Toland, Amanda Ewart, et al.
Publicado: (2018)

Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance
por: Sorscher, Steven, et al.
Publicado: (2017)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes
por: Caleca, Laura, et al.
Publicado: (2019)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
por: Fanale, Daniele, et al.
Publicado: (2021)

A preliminary investigation of genetic counselors’ information needs when receiving a variant of uncertain significance result: a mixed methods study
por: Scherr, Courtney L., et al.
Publicado: (2015)

Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
Publicado: (2022)

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
por: LaDuca, Holly, et al.
Publicado: (2014)

Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
por: Lovelock, Paul K, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_qn5u7uuqod4oojpj60gkntvhgj